KDR and breast cancer: Indeed, confocal microscopic observations showed that VEGFR2 blockade significantly increased mitochondrial fluorescence in both MCF-7 and MDA-MB-231 breast cancer cells, while flow cytometric analyses showed that VEGFR2 blockade elevated mitochondrial masses of both cancer cells up to 2-fold.